⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Aclaris Therapeutics, Inc.

$3.90
+0.00 (+0.00%)

Market Capitalization:

$545.31M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Aclaris Therapeutics Market Segments

After Hours

*No Trades in Segment

Regular Trading Hours

*No Trades in Segment

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$3.90
Close$3.90
Low$3.90
Low Change0.00 (0.00%)
High$3.90
High Change+0.00 (+0.00%)
Range$0.00
Volume328.643K
Dollar Volume$1.28M

Regular Trading Hours Yesterday

+0.28(+7.73%)
Open$3.62
Close$3.90
Low$3.61
Low Change-0.01 (-0.27%)
High$3.98
High Change+0.36 (+9.81%)
Range$0.36
Volume3.189M
Dollar Volume$12.44M

Premarket Yesterday

+0.25(+7.25%)
Open$3.45
Close$3.70
Low$3.45
Low Change0.00 (0.00%)
High$3.70
High Change+0.25 (+7.25%)
Range$0.25
Volume1.668K
Dollar Volume$6.17K

Aclaris Therapeutics News

There is no current news for this stock at the moment.

Aclaris Therapeutics Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Aclaris Therapeutics Moving Averages

5 Day Moving Average (SMA5)$3.75
10 Day Moving Average (SMA10)$3.82
20 Day Moving Average (SMA20)$3.70
50 Day Moving Average (SMA50)$4.62
100 Day Moving Average (SMA100)$5.11
200 Day Moving Average (SMA200)$4.53

Aclaris Therapeutics Statistics

Average Volume (30 Days)3.48M
P/E Ratio (Current)-7.51
EPS (Current)-$0.51
Dividend Yield0.00%
Free Cash Flow-$62.18M
Cash Ratio0.68
Current Ratio3.46
Quick Ratio3.46
Debt to Equity0.00
Enterprise Value$544.60M
EV to EBITDA-6.38
EV to Sales66.26
Price to Book4.53
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales68.59
Return on Assets-0.42%
Return on Equity-0.61%

Aclaris Therapeutics Stock Splits

There have been no stock splits for Aclaris Therapeutics (ACRS).

Aclaris Therapeutics Dividends

There have been no dividends for Aclaris Therapeutics (ACRS).